Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription 09.08.2021 1 Am J Med 4 Arch Virol 1 Biochemistry 1 BMJ 2 Cell 1 Epidemiol Infect 3 J Epidemiol Community Health 1 J Exp Med 2 J Immunol 4 J Infect 3 J Infect Dis 1 J Virol 1 J Virol Methods 11 Lancet 3 N Engl J Med 4 Pediatrics 1 PLoS Biol 4 PLoS Comput Biol 72 PLoS One 13 Proc Natl Acad Sci U S A 13 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. QUINN MJ
   Clinical Omissions in COVID-19.
   Am J Med. 2021;134:e463.
   PubMed        
   
   

   
   Arch Virol

2. LAVERACK M, Tallmadge RL, Venugopalan R, Cronk B, et al
   Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
   Arch Virol. 2021;166:2551-2561.
   PubMed         Abstract available
   
   
3. NAGY A, Basiouni S, Parvin R, Hafez HM, et al
   Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
   Arch Virol. 2021;166:2541-2549.
   PubMed         Abstract available
   
   
4. MARCHIO A, Batejat C, Vanhomwegen J, Feher M, et al
   ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.
   Arch Virol. 2021;166:2529-2540.
   PubMed         Abstract available
   
   
5. ABDELWAHAB SF, Mohamed MK, Ali WY, Ali AS, et al
   Role of polymeric materials in preventing COVID-19 infection.
   Arch Virol. 2021;166:2487-2493.
   PubMed         Abstract available
   
   

   
   Biochemistry

6. THOMASTON JL, Samways ML, Konstantinidi A, Ma C, et al
   Rimantadine Binds to and Inhibits the Influenza A M2 Proton Channel without Enantiomeric Specificity.
   Biochemistry. 2021 Aug 3. doi: 10.1021/acs.biochem.1c00437.
   PubMed         Abstract available
   
   

   
   BMJ

7. CROOK H, Raza S, Nowell J, Young M, et al
   Long covid-mechanisms, risk factors, and management.
   BMJ. 2021;374:n1648.
   PubMed         Abstract available
   
   

   
   Cell

8. WEINGARTEN-GABBAY S, Klaeger S, Sarkizova S, Pearlman LR, et al
   Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
   Cell. 2021;184:3962-3980.
   PubMed         Abstract available
   
   
9. COPIN R, Baum A, Wloga E, Pascal KE, et al
   The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
   Cell. 2021;184:3949-3961.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

10. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    PubMed         Abstract available
    
    

    
    J Epidemiol Community Health

11. MACDONALD I, Hsu JL
    Epidemiological observations on breaking COVID-19 transmission: from the experience of Taiwan.
    J Epidemiol Community Health. 2021;75:809-812.
    PubMed         Abstract available
    
    
12. DARAS K, Alexiou A, Rose TC, Buchan I, et al
    How does vulnerability to COVID-19 vary between communities in England? Developing a Small Area Vulnerability Index (SAVI).
    J Epidemiol Community Health. 2021;75:729-734.
    PubMed         Abstract available
    
    
13. ABURTO JM, Kashyap R, Scholey J, Angus C, et al
    Estimating the burden of the COVID-19 pandemic on mortality, life expectancy and lifespan inequality in England and Wales: a population-level analysis.
    J Epidemiol Community Health. 2021;75:735-740.
    PubMed         Abstract available
    
    

    
    J Exp Med

14. AHN M, Wang LF
    Translation from bats to humans beyond infectious diseases.
    J Exp Med. 2021;218.
    PubMed         Abstract available
    
    

    
    J Immunol

15. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
    Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
    PubMed         Abstract available
    
    
16. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
    TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    J Immunol. 2021;206:1315-1328.
    PubMed         Abstract available
    
    

    
    J Infect

17. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    PubMed        
    
    
18. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    PubMed        
    
    
19. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    PubMed        
    
    
20. CHEN J, Li X, Xu L, Xie S, et al
    Health threats from increased antigenicity changes in H5N6-dominant subtypes, 2020 China.
    J Infect. 2021;83:e9-e11.
    PubMed        
    
    

    
    J Infect Dis

21. SOUTHWICK FS
    Improving the Definition of Coronavirus Disease 2019-Related Deaths.
    J Infect Dis. 2021;224:375-376.
    PubMed        
    
    
22. AVIV R, Weber A, Anzum T, Federbush M, et al
    Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.
    J Infect Dis. 2021;224:557-559.
    PubMed        
    
    
23. ALLAN-BLITZ LT, Klausner JD
    Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.
    J Infect Dis. 2021;224:556-557.
    PubMed        
    
    

    
    J Virol

24. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    PubMed         Abstract available
    
    

    
    J Virol Methods

25. FINCH J, Zuckerman M, Smith M
    Investigating the sequence variation in the influenza A matrix genes during the 2017-2018 and 2018-2019 seasons in samples from a local population in London.
    J Virol Methods. 2021;297:114250.
    PubMed         Abstract available
    
    

    
    Lancet

26. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    PubMed        
    
    
27. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    PubMed        
    
    
28. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    PubMed        
    
    
29. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    PubMed        
    
    
30. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    PubMed        
    
    
31. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    PubMed        
    
    
32. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    PubMed        
    
    
33. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    PubMed        
    
    
34. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    PubMed        
    
    
35. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    PubMed        
    
    
36. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    PubMed        
    
    

    
    N Engl J Med

37. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    PubMed        
    
    
38. STRUYF F, Sadoff J, Douoguih M
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
    N Engl J Med. 2021;385.
    PubMed        
    
    
39. MADHI SA, Izu A, Pollard AJ
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
    N Engl J Med. 2021;385.
    PubMed        
    
    

    
    Pediatrics

40. CHUA KP, Volerman A, Conti RM
    Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
41. LANPHIER E, Mosley L, Antommaria AHM
    Assessing Visitor Policy Exemption Requests During the COVID-19 Pandemic.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
42. FITZPATRICK T, McNally JD, Stukel TA, Lu H, et al
    Family and Child Risk Factors for Early-Life RSV Illness.
    Pediatrics. 2021;147.
    PubMed         Abstract available
    
    
43. RAMBAUD J, Dauger S, Morin L, Bergounioux J, et al
    Bronchiolitis Admissions to Intensive Care During COVID.
    Pediatrics. 2021 Mar 17. pii: peds.2021-050103. doi: 10.1542/peds.2021-050103.
    PubMed        
    
    

    
    PLoS Biol

44. KISSLER SM, Fauver JR, Mack C, Olesen SW, et al
    Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
    PLoS Biol. 2021;19:e3001333.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

45. CHERIAN P, Krishna S, Menon GI
    Optimizing testing for COVID-19 in India.
    PLoS Comput Biol. 2021;17:e1009126.
    PubMed         Abstract available
    
    
46. GIBBS H, Nightingale E, Liu Y, Cheshire J, et al
    Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.
    PLoS Comput Biol. 2021;17:e1009162.
    PubMed         Abstract available
    
    
47. LI T, White LF
    Bayesian back-calculation and nowcasting for line list data during the COVID-19 pandemic.
    PLoS Comput Biol. 2021;17:e1009210.
    PubMed         Abstract available
    
    
48. NAUMOV V, Putin E, Pushkov S, Kozlova E, et al
    COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
    PLoS Comput Biol. 2021;17:e1009183.
    PubMed         Abstract available
    
    

    
    PLoS One

49. HEUVELINE P
    The Mean Unfulfilled Lifespan (MUL): A new indicator of the impact of mortality shocks on the individual lifespan, with application to mortality reversals induced by COVID-19.
    PLoS One. 2021;16:e0254925.
    PubMed         Abstract available
    
    
50. FURTH N, Shilo S, Cohen N, Erez N, et al
    Unified platform for genetic and serological detection of COVID-19 with single-molecule technology.
    PLoS One. 2021;16:e0255096.
    PubMed         Abstract available
    
    
51. HEIDEL A, Hagist C, Schlereth C
    Pricing through health apps generated data-Digital dividend as a game changer: Discrete choice experiment.
    PLoS One. 2021;16:e0254786.
    PubMed         Abstract available
    
    
52. SCHMUCK J, Hiebel N, Rabe M, Schneider J, et al
    Sense of coherence, social support and religiosity as resources for medical personnel during the COVID-19 pandemic: A web-based survey among 4324 health care workers within the German Network University Medicine.
    PLoS One. 2021;16:e0255211.
    PubMed         Abstract available
    
    
53. MARTINEZ D, Parilli C, Rojas AM, Scartascini C, et al
    Do you have COVID-19? How to increase the use of diagnostic and contact tracing apps.
    PLoS One. 2021;16:e0253490.
    PubMed         Abstract available
    
    
54. ABOUMRAD M, Shiner B, Riblet N, Huizenga H, et al
    Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study.
    PLoS One. 2021;16:e0246217.
    PubMed         Abstract available
    
    
55. MALLARI RJ, Avery MB, Corlin A, Eisenberg A, et al
    Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study.
    PLoS One. 2021;16:e0254958.
    PubMed         Abstract available
    
    
56. MARMET S, Wicki M, Gmel G, Gachoud C, et al
    The psychological impact of the COVID-19 crisis is higher among young Swiss men with a lower socioeconomic status: Evidence from a cohort study.
    PLoS One. 2021;16:e0255050.
    PubMed         Abstract available
    
    
57. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    PubMed         Abstract available
    
    
58. BOU-HAMAD I, Hoteit R, Harajli D
    Health worries, life satisfaction, and social well-being concerns during the COVID-19 pandemic: Insights from Lebanon.
    PLoS One. 2021;16:e0254989.
    PubMed         Abstract available
    
    
59. HLEDIK M, Polechova J, Beiglbock M, Herdina AN, et al
    Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program.
    PLoS One. 2021;16:e0255267.
    PubMed         Abstract available
    
    
60. YADAV UN, Yadav OP, Singh DR, Ghimire S, et al
    Perceived fear of COVID-19 and its associated factors among Nepalese older adults in eastern Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0254825.
    PubMed         Abstract available
    
    
61. LIU X, Ahmad Z, Gemeay AM, Abdulrahman AT, et al
    Modeling the survival times of the COVID-19 patients with a new statistical model: A case study from China.
    PLoS One. 2021;16:e0254999.
    PubMed         Abstract available
    
    
62. COZIER YC, Castro-Webb N, Hochberg NS, Rosenberg L, et al
    Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women.
    PLoS One. 2021;16:e0255132.
    PubMed         Abstract available
    
    
63. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    PubMed         Abstract available
    
    
64. KOOB C, Schropfer K, Coenen M, Kus S, et al
    Factors influencing study engagement during the COVID-19 pandemic: A cross-sectional study among health and social professions students.
    PLoS One. 2021;16:e0255191.
    PubMed         Abstract available
    
    
65. RAHMAN MA, Shanjana Y, Tushar MI, Mahmud T, et al
    Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh.
    PLoS One. 2021;16:e0255379.
    PubMed         Abstract available
    
    
66. YU Y, Li C, Yang W, Xu W, et al
    Determining the critical factors of air-conditioning innovation using an integrated model of fuzzy Kano-QFD during the COVID-19 pandemic: The perspective of air purification.
    PLoS One. 2021;16:e0255051.
    PubMed         Abstract available
    
    
67. PATUELLI A, Caldarelli G, Lattanzi N, Saracco F, et al
    Firms' challenges and social responsibilities during Covid-19: A Twitter analysis.
    PLoS One. 2021;16:e0254748.
    PubMed         Abstract available
    
    
68. WISSMATH B, Mast FW, Kraus F, Weibel D, et al
    Understanding the psychological impact of the COVID-19 pandemic and containment measures: An empirical model of stress.
    PLoS One. 2021;16:e0254883.
    PubMed         Abstract available
    
    
69. FLINSPACH AN, Booke H, Zacharowski K, Balaban U, et al
    High sedation needs of critically ill COVID-19 ARDS patients-A monocentric observational study.
    PLoS One. 2021;16:e0253778.
    PubMed         Abstract available
    
    
70. MARY-KRAUSE M, Herranz Bustamante JJ, Heron M, Andersen AJ, et al
    Impact of COVID-19-like symptoms on occurrence of anxiety/depression during lockdown among the French general population.
    PLoS One. 2021;16:e0255158.
    PubMed         Abstract available
    
    
71. BABICKA-WIRKUS A, Wirkus L, Stasiak K, Kozlowski P, et al
    University students' strategies of coping with stress during the coronavirus pandemic: Data from Poland.
    PLoS One. 2021;16:e0255041.
    PubMed         Abstract available
    
    
72. YANG XD, Su XY, Li HL, Ma RF, et al
    Impacts of socio-economic determinants, spatial distance and climate factors on the confirmed cases and deaths of COVID-19 in China.
    PLoS One. 2021;16:e0255229.
    PubMed         Abstract available
    
    
73. HOU C, Jiang H
    Methodology of emergency medical logistics for multiple epidemic areas in public health emergency.
    PLoS One. 2021;16:e0253978.
    PubMed         Abstract available
    
    
74. SHAULY-AHARONOV M, Shafrir A, Paltiel O, Calderon-Margalit R, et al
    Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study.
    PLoS One. 2021;16:e0254847.
    PubMed         Abstract available
    
    
75. DESVAUX E, Hamon A, Hubert S, Boudjeniba C, et al
    Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.
    PLoS One. 2021;16:e0254374.
    PubMed         Abstract available
    
    
76. GHONIMI TAL, Alkad MM, Abuhelaiqa EA, Othman MM, et al
    Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study.
    PLoS One. 2021;16:e0254246.
    PubMed         Abstract available
    
    
77. SCARPINA F, Godi M, Corna S, Seitanidis I, et al
    Psychological functioning in survivors of COVID-19: Evidence from recognition of fearful facial expressions.
    PLoS One. 2021;16:e0254438.
    PubMed         Abstract available
    
    
78. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    PubMed         Abstract available
    
    
79. CHEN PY, Ko CH, Wang CJ, Chen CW, et al
    The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic.
    PLoS One. 2021;16:e0254486.
    PubMed         Abstract available
    
    
80. STRASSER S, Stauber C, Shrivastava R, Riley P, et al
    Collective insights of public-private partnership impacts and sustainability: A qualitative analysis.
    PLoS One. 2021;16:e0254495.
    PubMed         Abstract available
    
    
81. ZHOU Y, O'Leary TJ
    Relative sensitivity of anterior nares and nasopharyngeal swabs for initial detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis.
    PLoS One. 2021;16:e0254559.
    PubMed         Abstract available
    
    
82. GROSSMANN G, Backenkohler M, Wolf V
    Heterogeneity matters: Contact structure and individual variation shape epidemic dynamics.
    PLoS One. 2021;16:e0250050.
    PubMed         Abstract available
    
    
83. GUAN G, Dery Y, Yechezkel M, Ben-Gal I, et al
    Early detection of COVID-19 outbreaks using human mobility data.
    PLoS One. 2021;16:e0253865.
    PubMed         Abstract available
    
    
84. SANCHEZ-ARENAS R, Doubova SV, Gonzalez-Perez MA, Perez-Cuevas R, et al
    Factors associated with COVID-19 preventive health behaviors among the general public in Mexico City and the State of Mexico.
    PLoS One. 2021;16:e0254435.
    PubMed         Abstract available
    
    
85. GUO K, Zhang X, Bai S, Minhat HS, et al
    Assessing social support impact on depression, anxiety, and stress among undergraduate students in Shaanxi province during the COVID-19 pandemic of China.
    PLoS One. 2021;16:e0253891.
    PubMed         Abstract available
    
    
86. KEIL R, Hlava S, Stanovsky P, Zdimal V, et al
    Commonly available but highly effective protection against SARS-CoV-2 during gastrointestinal endoscopies.
    PLoS One. 2021;16:e0254979.
    PubMed         Abstract available
    
    
87. JANAKA SK, Clark NM, Evans DT, Mou H, et al
    Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay.
    PLoS One. 2021;16:e0253551.
    PubMed         Abstract available
    
    
88. WEAVER DT, McElvany BD, Gopalakrishnan V, Card KJ, et al
    UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic.
    PLoS One. 2021;16:e0241734.
    PubMed         Abstract available
    
    
89. TASAKIS RN, Samaras G, Jamison A, Lee M, et al
    SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.
    PLoS One. 2021;16:e0255169.
    PubMed         Abstract available
    
    
90. MEIS-PINHEIRO U, Lopez-Segui F, Walsh S, Ussi A, et al
    Clinical characteristics of COVID-19 in older adults. A retrospective study in long-term nursing homes in Catalonia.
    PLoS One. 2021;16:e0255141.
    PubMed         Abstract available
    
    
91. HOEK JM, Field SM, de Vries YA, Linde M, et al
    Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings.
    PLoS One. 2021;16:e0255093.
    PubMed         Abstract available
    
    
92. SCHNELL E, Karamooz E, Harriff MJ, Yates JE, et al
    Construction and validation of an ultraviolet germicidal irradiation system using locally available components.
    PLoS One. 2021;16:e0255123.
    PubMed         Abstract available
    
    
93. BONOMI BEZZO F, Silva L, van Ham M
    The combined effect of Covid-19 and neighbourhood deprivation on two dimensions of subjective well-being: Empirical evidence from England.
    PLoS One. 2021;16:e0255156.
    PubMed         Abstract available
    
    
94. IJKEMA R, Janssens MJPA, van der Post JAM, Licht CM, et al
    Ethical review of COVID-19 research in the Netherlands; a mixed-method evaluation among medical research ethics committees and investigators.
    PLoS One. 2021;16:e0255040.
    PubMed         Abstract available
    
    
95. DIXON BE, Grannis SJ, Lembcke LR, Valvi N, et al
    The synchronicity of COVID-19 disparities: Statewide epidemiologic trends in SARS-CoV-2 morbidity, hospitalization, and mortality among racial minorities and in rural America.
    PLoS One. 2021;16:e0255063.
    PubMed         Abstract available
    
    
96. COSTA ML, Souza RT, Pacagnella RC, Bento SF, et al
    Facing the COVID-19 pandemic inside maternities in Brazil: A mixed-method study within the REBRACO initiative.
    PLoS One. 2021;16:e0254977.
    PubMed         Abstract available
    
    
97. MARTINEZ ME, Capella Gonzalez C, Huey D, Peeples ME, et al
    Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats.
    PLoS One. 2021;16:e0246770.
    PubMed         Abstract available
    
    
98. SWAIN PK, Tripathy MR, Priyadarshini S, Acharya SK, et al
    Forecasting suicide rates in India: An empirical exposition.
    PLoS One. 2021;16:e0255342.
    PubMed         Abstract available
    
    
99. GALARNEAU LR, Hilburt J, O'Neill ZR, Buxton JA, et al
    Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0255396.
    PubMed         Abstract available
    
    
100. HU D, Zhang H, Sun Y, Li Y, et al
     The effects of the measures against COVID-19 pandemic on physical activity among school-aged children and adolescents (6-17 years) in 2020: A protocol for systematic review.
     PLoS One. 2021;16:e0255520.
     PubMed         Abstract available
     
     
101. NGUYEN HTT, Dinh DX, Nguyen VM
     Knowledge, attitude and practices of community pharmacists regarding COVID-19: A paper-based survey in Vietnam.
     PLoS One. 2021;16:e0255420.
     PubMed         Abstract available
     
     
102. MIRAGLIA JL, Nascimento Monteiro C, Giannecchini Romagnolo A, Xavier Gomes R, et al
     A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of Sao Paulo, Brazil.
     PLoS One. 2021;16:e0255412.
     PubMed         Abstract available
     
     
103. MARQUIONI VM, de Aguiar MAM
     Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.
     PLoS One. 2021;16:e0255438.
     PubMed         Abstract available
     
     
104. RAHMAN T, Hasnain MDG, Islam A
     Food insecurity and mental health of women during COVID-19: Evidence from a developing country.
     PLoS One. 2021;16:e0255392.
     PubMed         Abstract available
     
     
105. TAGHIOFF SM, Slavin BR, Holton T, Singh D, et al
     Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.
     PLoS One. 2021;16:e0255541.
     PubMed         Abstract available
     
     
106. AKHTAR Z, Chowdhury F, Rahman M, Ghosh PK, et al
     Seasonal influenza during the COVID-19 pandemic in Bangladesh.
     PLoS One. 2021;16:e0255646.
     PubMed         Abstract available
     
     
107. ABREU RB, Kirchenbaum GA, Sautto GA, Clutter EF, et al
     Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.
     PLoS One. 2021;16:e0254421.
     PubMed         Abstract available
     
     
108. BOUDOU M, OhAiseadha C, Garvey P, O'Dwyer J, et al
     Breakpoint modelling of temporal associations between non-pharmaceutical interventions and symptomatic COVID-19 incidence in the Republic of Ireland.
     PLoS One. 2021;16:e0255254.
     PubMed         Abstract available
     
     
109. ARAMBEPOLA C, Wickramasinghe ND, Jayakody S, Hewage SA, et al
     Sri Lanka's early success in the containment of COVID-19 through its rapid response: Clinical & epidemiological evidence from the initial case series.
     PLoS One. 2021;16:e0255394.
     PubMed         Abstract available
     
     
110. POSTIGO-ZEGARRA S, Julian M, Schoeps K, Montoya-Castilla I, et al
     Psychological adjustment of Spanish adolescents and their parents during COVID-19 lockdown: A mixed method approach.
     PLoS One. 2021;16:e0255149.
     PubMed         Abstract available
     
     
111. EL HAGE J, Gravitt P, Ravel J, Lahrichi N, et al
     Supporting scale-up of COVID-19 RT-PCR testing processes with discrete event simulation.
     PLoS One. 2021;16:e0255214.
     PubMed         Abstract available
     
     
112. LEE CM, Juarez M, Rae G, Jones L, et al
     Anxiety, PTSD, and stressors in medical students during the initial peak of the COVID-19 pandemic.
     PLoS One. 2021;16:e0255013.
     PubMed         Abstract available
     
     
113. MISTRY SK, Ali ARMM, Yadav UN, Ghimire S, et al
     Older adults with non-communicable chronic conditions and their health care access amid COVID-19 pandemic in Bangladesh: Findings from a cross-sectional study.
     PLoS One. 2021;16:e0255534.
     PubMed         Abstract available
     
     
114. KATZENSCHLAGER S, Zimmer AJ, Gottschalk C, Grafeneder J, et al
     Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?
     PLoS One. 2021;16:e0255154.
     PubMed         Abstract available
     
     
115. HABIBI M, Taheri G
     Topological network based drug repurposing for coronavirus 2019.
     PLoS One. 2021;16:e0255270.
     PubMed         Abstract available
     
     
116. KLEITMAN S, Fullerton DJ, Zhang LM, Blanchard MD, et al
     To comply or not comply? A latent profile analysis of behaviours and attitudes during the COVID-19 pandemic.
     PLoS One. 2021;16:e0255268.
     PubMed         Abstract available
     
     
117. WILDE H, Dennis JM, McGovern AP, Vollmer SJ, et al
     A national retrospective study of the association between serious operational problems and COVID-19 specific intensive care mortality risk.
     PLoS One. 2021;16:e0255377.
     PubMed         Abstract available
     
     
118. RAINES KS, Doniach S, Bhanot G
     The transmission of SARS-CoV-2 is likely comodulated by temperature and by relative humidity.
     PLoS One. 2021;16:e0255212.
     PubMed         Abstract available
     
     
119. ZHANG Y, Khullar D, Wang F, Steel P, et al
     Socioeconomic variation in characteristics, outcomes, and healthcare utilization of COVID-19 patients in New York City.
     PLoS One. 2021;16:e0255171.
     PubMed         Abstract available
     
     
120. WADHWA A, Yin S, Freeman B, Hershow RB, et al
     Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies.
     PLoS One. 2021;16:e0255208.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

121. HAN X, Xu Y, Fan L, Huang Y, et al
     Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
122. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
     Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
123. ZHANG H, Zhu W, Jin Q, Pan F, et al
     Inhalable nanocatchers for SARS-CoV-2 inhibition.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
124. ROCHMAN ND, Wolf YI, Faure G, Mutz P, et al
     Ongoing global and regional adaptive evolution of SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
125. IRONS NJ, Raftery AE
     Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
126. PINK SL, Chu J, Druckman JN, Rand DG, et al
     Elite party cues increase vaccination intentions among Republicans.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
127. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
     Emphasize personal health benefits to boost COVID-19 vaccination rates.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
128. ARCHIBONG B, Metcalf CJE
     Building toward useful SARS-CoV-2 models in Africa.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed        
     
     
129. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
     Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
130. PARRY R, Gifford RJ, Lytras S, Ray SC, et al
     No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed        
     
     
131. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
     Response to Parry et al.: Strong evidence for genomic integration of SARS-CoV-2 sequences and expression in patient tissues.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed        
     
     
132. KERR GH, Goldberg DL, Anenberg SC
     COVID-19 pandemic reveals persistent disparities in nitrogen dioxide pollution.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
133. BAKER A, Biazzo I, Braunstein A, Catania G, et al
     Epidemic mitigation by statistical inference from contact tracing data.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     

     
     Vaccine

134. REDONDO E, Drago G, Lopez-Belmonte JL, Guillen JM, et al
     Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
     Vaccine. 2021 Jul 31. pii: S0264-410X(21)00926.
     PubMed         Abstract available
     
     
135. HSIA J, Zhao G, Lu PJ, Town M, et al
     Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
     Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
     PubMed         Abstract available
     
     
136. IVANOV V, Oomens AGP, Papin JF, Staats R, et al
     Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
     Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
     PubMed         Abstract available
     
     
137. PRASAD N, Read JM, Jewell C, Waite B, et al
     Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
     Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
     PubMed         Abstract available
     
     
138. HERVE PL, Dhelft V, Zuniga A, Ghasparian A, et al
     Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
     Vaccine. 2021;39:4555-4563.
     PubMed         Abstract available
     
     
139. CARCELEN AC, Vilajeliu A, Malik F, Gilman RH, et al
     Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru.
     Vaccine. 2020 Oct 30. pii: S0264-410X(20)31325.
     PubMed         Abstract available
     
     
140. RAGHUNANDAN R, Higgins D, Hosken N
     RSV neutralization assays - Use in immune response assessment.
     Vaccine. 2021;39:4591-4597.
     PubMed         Abstract available
     
     
141. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
     Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
     Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
     PubMed         Abstract available
     
     
142. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
     One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
     Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
     PubMed         Abstract available
     
     
143. MACINTYRE CR, Veness B, Berger D, Hamad N, et al
     Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
     Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
     PubMed         Abstract available
     
     
144. MOGAJI E
     Marketing the COVID-19 vaccine and the implications for public health.
     Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
     PubMed         Abstract available
     
     
145. DIACO M, Yin K, Seet B, Samson S, et al
     Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
     Vaccine. 2021 Jul 28. pii: S0264-410X(21)00917.
     PubMed        
     
     
146. AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
     COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
     Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.
     PubMed        
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: